About Us

Making comprehensive genomic profiling available to patients around the world

Roche and Foundation Medicine® Collaboration

Roche is making Foundation Medicine's comprehensive genomic profiling services available to patients outside of the United States. 

As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation, and experience in cancer profiling, together we’re:1

  • Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
  • Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials

Foundation Facts

  • >200k
    patients profiled2
  • >150
    common and rare tumour subtypes profiled2
  • >300

Need More Details?

Our dedicated client service team offers assistance throughout the process and our medical team is available to support you with interpretation of the report on request.